Tuesday, December 15, 2009

PLAN TO Participate in DHS QIS STAKEHOLDER CALL

Date & Time: January 7, 2010 10:00 am – 11:30 am (MST)

Dial – In Information:

Dial-In number: 1-866-294-4838 or Alternate Dial-In number: 1-847-944-7303

Passcode: 5560598#

Presentation PowerPoint on Web: http://www.nursinghomequality.com/az_qisoverview

As a stakeholder and long term care provider….DHS is inviting you to participate in an “Information” conference call regarding the implementation of the QIS process in Arizona. Be sure to include other attendees from your organization as you feel appropriate. This will be a critical opportunity to receive an update on the implementation status of the QIS in Arizona- DON’T MISS IT!

Friday, December 11, 2009

Skilled Facility QIS Webnar January

Arizona Department of Health Services

Division of Licensing

Office of Long Term care Licensing

Stakeholder/Provider QIS Information Call

Date & Time: January 7, 2010 10:00 am – 11:30 am (MST)

Dial – In Information:

Dial-In number: 1-866-294-4838

Alternate Dial-In number: 1-847-944-7303

Passcode: 5560598#

Location of Presentation PowerPoint on Web:

http://www.nursinghomequality.com/az_qisoverview

Call Agenda:

1. Welcome and Introductions – Katherine Lochary, CMS

2. Background and Development of the Quality Indicator Survey (QIS) – Karen Schoeneman, CMS

3. National QIS Training Process - Katherine Lochary, CMS

4. Description and Timing of State QIS Implementation – Sylvia Balistreri, AZ Office of LTC Licensing, Program Manager, QIS Lead

5. QIS Overview – Dr. Andrew Kramer, University of Colorado Denver, Division of Health Care Policy and Research

6. Comparison of the QIS and Traditional Survey Process – Andrew Kramer

7. Impact of QIS on Survey Process – Andrew Kramer

8. Questions and Answers

National Transitions of Care Coalition

Improving Transitions of Care

The National Transitions of Care Coalition (NTOCC) is a coalition of 30 diverse organizations dedicated to providing solutions that improve the quality of health care with better collaboration between providers, patients, and caregivers. The term "transitions of care" connotes the scenario of a patient leaving one care setting (i.e., hospital, nursing facility, assisted living facility, primary care physician care, home health care, or specialist care) and moving to another.

In the U.S. health and long-term care system, many patients experience transitions of care. Between 41.9 and 70 percent of Medicare patients admitted to the hospital for care in 2003 in the U.S.

received services from an average of 10 or more physicians during their stay.1 In Arkansas, among the total number of discharges (154,506 between ages 65 to 85+) of

hospitalized patients aged 65 to 84, 23.05 percent are discharged to another institution, and nearly 13.22 percent receive home health care. In the 85+ age group, 45.98% are discharged to another institution and 13.48% receive home health care. 2

On average, patients 65 or older with two or more chronic conditions see seven different physicians within one year, accounting for 95 percent of Medicare expenditures.3

Miscommunication during transitions of care can reduce the quality of care significantly, leading to:

Medication errors, both overuse and sub-optimal use of prescription drugs harm an estimated 1.5 million people each year in the United States, costing the nation at least $3.5 billion annually;4

Patient and caregiver confusion about patient's condition and appropriate care;

Lack of follow-through on referrals; and

Increased costs because missing test results, discharge summaries, referrals, and medication lists may require patients to schedule redundant appointments or may lead providers to prescribe duplicative medications.

NTOCC believes the following considerations are important to better transitions of care:

Improve communication during transitions between providers, patients, and caregivers; Implement electronic medical records that include standardized medication reconciliation elements; Establish points of accountability for sending and receiving care, particularly for hospitalists, SNFists

(physicians practicing in skilled nursing facilities), primary care physicians, and specialists; Increase the use of case management and professional care coordination; Expand the role of the pharmacist in transitions of care; Implement payment systems that align incentives; and Develop performance measures to encourage better transitions of care.

Learn more at www.NTOCC.org.

Wednesday, December 9, 2009

Paige Hector MSW gives this advice.

I can across a short piece in an article that provides resources for people who can't afford medications. I have not researched the sites but still wanted to pass them along. They come from a reputable magazine. For those of you who work in the long-term care industry, please pass this information along to your social workers and case managers.
1. Check for discounts from manufacturer websites, i.e. www.pfizerhelpfulanswers.com
2. See if the person qualifies for reduced-price drugs through programs run by patient-advocacy groups and healthcare providers. Go to www.pparx.org for details.
3. Try signing up for a drug savings card (go to www.freedrugcard.us or www.rxfreecard.com ). It may grant discounts at participating pharmacies.

Thursday, October 29, 2009

Nutrition at the End of Life

Great reference can be had for this issue on the American Society of Parenteral and Enteral Nutrition or the direct reference as follows:

Journal of Parenteral and Enteral Nutrition, Vol. 33, No. 3, 277-316 (2009) Pg: 308DOI: 10.1177/0148607109335234

I like that they approach the issue using the term 'futile care'.

Note that this site is a great reference for free guidelines so long as you sign-up for free.

Sunday, October 25, 2009

Hospice Fails Nursing Homes -- Are We Getting Value?

Majority of Nursing Homes Fail to Meet Medicare Requirements for Hospice Services
(9/14/2009)

ALEXANDRIA, VA.—The Department of Health and Human Services Office of the Inspector General issued the final two reports in a series of four, which reviewed the hospice benefit for residents of nursing facilities. The report indicated that 82% of the 470 claims that were part of the study did not meet at least one Medicare coverage requirement for hospice services. Among the OIG's recommendations were increased hospice provider education, tools fostering better compliance, and strengthened monitoring of practices, such as medical review and additional surveys.

The study, using a sample of 470 claim forms from 2006, highlighted technical compliance issues with the medical record that included forms that did not meet election requirements (33%), issues relating to plan of care requirements (63%), and hospices providing fewer services than outlined in the beneficiaries' plans of care (31%).

Despite Medicare requirements not being met, the National Hospice and Palliative Care Organization (NHPCO), which gathers data on the quality of hospice care from bereaved family members, indicated slightly over two-thirds of 30,000 surveyed families have rated the quality of hospice care provided in nursing homes as excellent. NHPCO has voiced strong support of the OIG’s recommendations.

Skin Changes at Life's End (SCALE) Document Released

Great news as the SCALE (Skin Changes at Life's End) document is finally released. A must document for all involved with skin changes in residents in our long-term care institutions!!!


SCALE Final Consensus Statement October 1, 2009

Abstract An expert panel was established to formulate a consensus statement on Skin Changes At Life’s End (SCALE). The panel consists of 18 internationally recognized key opinion leaders including clinicians, caregivers, medical researchers, legal experts, academicians, a medical writer and leaders of professional organizations. The inaugural forum was held on April 4‐6, 2008 in Chicago, IL, and was made possible by an unrestricted educational grant from Gaymar Industries, Inc. The panel discussed the nature of SCALE, including the proposed concepts of the Kennedy Terminal Ulcer (KTU) and skin failure along with other end of life skin changes. The final consensus document and statements were edited and reviewed by the panel after the meeting. The document and statements were initially externally reviewed by 49 international distinguished reviewers. A modified Delphi process was used to determine the final statements and 52 international distinguished reviewers reached consensus on the final statements.

The skin is the body’s largest organ and like any other organ is subject to a loss of integrity. It has an increased risk for injury due to both internal and external insults. The panel concluded that: our current comprehension of skin changes that can occur at life’s end is limited; that SCALE process is insidious and difficult to prospectively determine; additional research and expert consensus is necessary; and contrary to popular myth, not all pressure ulcers are avoidable.

Specific areas requiring research and consensus include: 1) the identification of critical etiological and pathophysiological factors involved in SCALE, 2) clinical and diagnostic criteria for describing conditions identified with SCALE, and 3) recommendations for evidence‐informed pathways of care.

The statements from this consensus document are designed to facilitate the implementation of knowledge‐transfer‐into‐practice techniques for quality patient outcomes. This implementation process should include interprofessional teams (clinicians, lay people and policy makers) concerned with the care of individuals at life’s end to adequately address the medical, social, legal, and financial ramifications of SCALE.

The content of this document is based on the results of a two‐day round table discussion held on April 4‐6, 2008 in Chicago, IL, and was made possible by an unrestricted educational grant from Gaymar Industries, Inc. Additional input was received from international panels of 49 and 52 distinguished reviewers using a modified Delphi Method process. The information contained herein does not necessarily represent the opinions of all panel members, distinguished reviewers, or Gaymar Industries, Inc.

Disclaimer: The content of this document is intended for general information purposes and is not intended to be a substitute for medical or legal advice. Do not rely on information in this article in place of medical or legal advice.

Copyright 2009 Skin Changes At Life’s End (SCALE) Expert Panel. All rights reserved.

1Skin Changes At Life’s End (SCALE): Ten Consensus Statement © 2009 SCALE Expert Panel SCALE Expert Panel Members

Co‐Chairpersons:

R. Gary Sibbald, BSc, MD, FRCPC (Med, Derm),MACP, FAAD, MEd, FAPWCA University of Toronto, Toronto, Canada, gary.sibbald@utoronto.ca

Diane L. Krasner, PhD, RN, CWCN, CWS, BCLNC, FAAN, Wound & Skin Care Consultant, York, PA, USA, dlkrasner@aol.com Corresponding Author: 212 East Market Street, York, PA 17403 USA

Medical Writer:

James Lutz, MS, CCRA, Lutz Consulting, LLC, Medical Writing Services, Buellton, CA, USA, jlutzmail@aol.com Panel Facilitator:

Cynthia Sylvia, MSc, MA, RN, CWOCN, Gaymar Industries, Inc., Orchard Park, NY, USA, csylvia@gaymar.com

Additional Panel Members:

Oscar Alvarez, PhD, CCT, FAPWCA, Center for Curative and Palliative Wound Care, Calvary Hospital, Bronx, NY, USA, oalvarez@calvaryhospital.org

Elizabeth A. Ayello, PhD, RN, ACNS‐BC, ETN, FAPWCA, FAAN, Excelsior College School of Nursing, USA, elizabeth @ayello.com

Sharon Baranoski, MSN, RN, CWOCN, APN, DAPWCA, FAAN, Wound Care Dynamics, Inc., Shorewood, IL, USA, nrsebear@aol.com

William J. Ennis, DO, MBA, FACOS, University of Illinois, Palos Heights, IL, USA, w.ennis@comcast.net Nancy Ann Faller, RN, MSN, PhD, ETN, CS, Carlisle, PA, USA, nafaller@aol.com

Jane Hall, Medical Malpractice Defense Attorney, Huie, Fernambucq & Stewart, LLP, Birmingham, AL, USA, jgh@hfsllp.com

Rick E. Hall, BA, RN, CWCN, Helping Hands Wound Care, Wichita, KS, USA, mnurse66@yahoo.com

Karen Lou Kennedy‐Evans, RN, CS, FNP, KL Kennedy, LLC, Tucson, AZ, USA, ktulcer@aol.com

Diane Langemo, PhD, RN, FAAN, Langemo & Assoc, Grand Forks, ND, USA, dianelangemo@aol.com

Joy Schank, RN, MSN, ANP, CWOCN, Schank Companies, Himrod, NY, USA, joyschank@yahoo.com

Thomas P. Stewart, PhD, Gaymar Industries, Inc., Orchard Park, NY & S.U.N.Y. at Buffalo, USA, tstewart@gaymar.com

Nancy A. Stotts, RN, CNS, EdD, FAAN, University of California, San Francisco, San Francisco, CA, USA, nancy.stotts@nursing.ucsf.edu

David R. Thomas, MD, FACP, AGSF, GSAF, CMD, St. Louis University, St. Louis, MO, USA, thomasdr@slu.edu

Dot Weir, RN, CWON, CWS, Osceola Regional Medical Center, Kissimmee, FL, USA, dorothy.weir@hcahealthcare.com

2

Skin Changes At Life’s End (SCALE): Ten Consensus Statement © 2009 SCALE Expert Panel Panel Statements

Statement 1: Physiologic changes that occur as a result of the dying process may affect the skin and soft tissues and may manifest as observable (objective) changes in skin color, turgor, or integrity, or as subjective symptoms such as localized pain. These changes can be unavoidable and may occur with the application of appropriate interventions that meet or exceed the standard of care.

Statement 2: The plan of care and patient response should be clearly documented and reflected in the entire medical record. Charting by exception is an appropriate method of documentation.

Statement 3: Patient centered concerns should be addressed including pain and activities of daily living. Statement 4: Skin changes at life’s end are a reflection of compromised skin (reduced soft tissue perfusion,

decreased tolerance to external insults, and impaired removal of metabolic wastes).

Statement 5: Expectations around the patient’s end of life goals and concerns should be communicated among the members of the interprofessional team and the patient’s circle of care. The discussion should include the potential for SCALE including other skin changes, skin breakdown and pressure ulcers.

Statement 6: Risk factors symptoms and signs associated with SCALE have not been fully elucidated, but may include:

• Weakness and progressive limitation of mobility. • Suboptimal nutrition including loss of appetite, weight loss, cachexia and wasting, low serum

albumin/pre‐albumin, and low hemoglobin as well as dehydration. • Diminished tissue perfusion, impaired skin oxygenation, decreased local skin temperature, mottled

discoloration, and skin necrosis. • Loss of skin integrity from any of a number of factors including equipment or devices, incontinence,

chemical irritants, chronic exposure to body fluids, skin tears, pressure, shear, friction, and infections. • Impaired immune function.

Statement 7: A total skin assessment should be performed regularly and document all areas of concern consistent with the wishes and condition of the patient. Pay special attention to bony prominences and skin areas with underlying cartilage. Areas of special concern include the sacrum, coccyx, ischial tuberosities, trochanters, scapulae, occiput, heels, digits, nose and ears. Describe the skin or wound abnormality exactly as assessed.

Statement 8: Consultation with a qualified health care professional is recommended for any skin changes associated with increased pain, signs of infection, skin breakdown (when the goal may be healing), and whenever the patient’s circle of care expresses a significant concern.

Statement 9: The probable skin change etiology and goals of care should be determined. Consider the 5 Ps for determining appropriate intervention strategies:

• Prevention • Prescription (may heal with appropriate treatment) • Preservation (maintenance without deterioration) • Palliation (provide comfort and care) • Preference (patient desires)

Statement 10: Patients and concerned individuals should be educated regarding SCALE and the plan of care.

Nursing Home New Survey Process

Our nursing homes in Arizona are getting geared up for the new survey process for 2010. Continue to view here for updates on how the Department of Health in Arizona, and state surveyors across the country, are accomplishing this process.